Udayavni Special

SC directs Centre to revisit current vaccine policy, says it may create disparity

Will return to India in a few days, says Adar Poonawalla

Over 79L COVID-19 vaccine doses available with States/UTs, says Centre

‘Indian strain’ of SARS-CoV-2 spreads faster, but little evidence of it being more lethal, say experts

US to immediately provide raw materials required for manufacturing Covishield in India; sending life-saving supplies

Serum Institute defends vaccine pricing, says initial rates based on advance funding

Karnataka to purchase 1 crore doses of Covishield vaccine for Rs 400 crore

Over 21k tested positive for COVID after taking first dose of either Covishield or Covaxin: Govt

Congress demands one nation, one price for COVID vaccines

Serum prices COVID vaccine for pvt hospitals at Rs 600/dose; for state govts at Rs 400/dose

SII CEO urges US to lift raw material export ban to ramp up vaccine production

7 blood clot deaths after 18.1 mn jabs, AstraZeneca vaccine safe, states UK regulator

DCGI extends shelf life of Covishield from 6 to 9 months

Serum Institute seeks govt’s intervention over import of COVID vaccine raw material from US

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials

Over 8.25L vaccinated in Karnataka so far reports Health Dept

Man from Chikkaballapur dies nine days after receiving Covishield jab

18-19 anti-COVID-19 vaccines in pipeline says Health Min Vardhan

25 countries in queue for “Made In India” COVID-19 vaccine says EAM

Second dose of anti-COVID-19 vaccine to be administered to healthcare workers from Feb 13

PM-CARES Fund to foot over 80% cost of 1st phase of COVID vaccination drive

Relief for SII as court rejects trademark-violation plea over ‘Covishield’

Airlifted COVID vaccines to 9 countries, will gradually supply to WHO’s COVAX facility informs India at UN

Fire in Serum Institute; Covishield facility not affected

COVID-19 vaccines sent by India reach Bhutan and Maldives

DK district receives 2nd batch of COVID-19 vaccine

Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute

62% of designated beneficiaries vaccinated on day one in Karnataka

Health experts in Karnataka receive COVID-19 vaccine shots, say its ”safe”

More than 240 centres ready for vaccination drive in K’taka

Nepal approves AstraZeneca’s India-made COVID-19 vaccine for emergency use

Efficacy of vaccine: Recipients don’t have the option to choose one vaccine over the other

Experts’ group slam critics of India’s COVID-19 vaccines approval process

Two districts of K’taka receive over two lakh doses of Covishield

Latest Additions

Karnataka reports 48781 new COVID-19 cases, 592 deaths

Accused arms dealer Sanjay Bhandari bail in UK extradition case extended to May 13

Highest single day fatality count shows curfew not effective: K Sudhakar

Not right time to mislead people, MLA Kamath to Congress

Lockdown extended till May 24 in K’taka

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.